Researchers have identified several mediators, including indoleamine 2, 3-dioxygenase (IDO), matrix metalloproteinases (MMPs), TGF-β, and IL-10, that contribute to immune suppression in pancreatic cancer, impeding the ability of NK cells to recognize and eliminate tumor cells [28]. Here, TGFB1 is linked to neoplasm.